These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1460419)

  • 21. Variable rate of detection of immunoglobulin heavy chain V-D-J rearrangement by PCR: a systematic study of 41 B-cell non-Hodgkin's lymphomas and leukemias.
    Ben-Ezra J
    Leuk Lymphoma; 1992 Jul; 7(4):289-95. PubMed ID: 1493428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.
    Kiyoi H; Naoe T; Horibe K; Ohno R
    J Clin Invest; 1992 Mar; 89(3):739-46. PubMed ID: 1541668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of somatic hypermutation of immunoglobulin heavy chain variable region genes in precursor B-lymphoblastic lymphoma: a study of four cases in childhood and adolescence.
    Hojo H; Sasaki Y; Nakamura N; Abe M
    Am J Clin Pathol; 2001 Nov; 116(5):673-82. PubMed ID: 11710683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of 5' J region of immunoglobulin heavy chain gene in human acute leukemias.
    Ozaki M; Asada M; Tamura C; Zhong WK; Nakamura K; Fujimoto J; Miyashita T; Kobayashi N; Mizutani S
    Leukemia; 1990 Jun; 4(6):415-8. PubMed ID: 1972769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the complementary determining region III of the immunoglobulin heavy chain locus in acute lymphoblastic leukemia in Chilean children.
    Barriga FJ; RisueNo C; Patillo JC; Andrade W; Cabrera ME; Beressi V; Del Borgo P; Salgado C; Becker A; Campbell M; Bertin P
    Leukemia; 1996 Nov; 10(11):1719-23. PubMed ID: 8892674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
    Deane M; Norton JD
    Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of clonal immunoglobulin gene rearrangements in the PBPC harvests of patients with acute lymphoblastic leukaemia.
    Owen RG; Johnson RJ; Evans PA; Smith GM; Child JA; Morgan GJ
    Bone Marrow Transplant; 1995 Dec; 16(6):831-4. PubMed ID: 8750277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts.
    Tuaillon N; Taylor LD; Lonberg N; Tucker PW; Capra JD
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3720-4. PubMed ID: 8475122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong antigenic selection shaping the immunoglobulin heavy chain repertoire of B-1a lymphocytes in lambda 2(315) transgenic mice.
    Kretschmer K; Engel H; Weiss S
    Eur J Immunol; 2002 Aug; 32(8):2317-27. PubMed ID: 12209645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential utilization of the immature JH segment and absence of somatic mutation in the CDR3 junction of the Ig H chain gene in three X-linked severe combined immunodeficiency patients.
    Minegishi Y; Okawa H; Sugamura K; Yata J
    Int Immunol; 1994 Nov; 6(11):1709-15. PubMed ID: 7865464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
    Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
    Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restricted utilization of germ-line VH3 genes and short diverse third complementarity-determining regions (CDR3) in human fetal B lymphocyte immunoglobulin heavy chain rearrangements.
    Raaphorst FM; Timmers E; Kenter MJ; Van Tol MJ; Vossen JM; Schuurman RK
    Eur J Immunol; 1992 Jan; 22(1):247-51. PubMed ID: 1730252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable kappa gene rearrangement in lymphoproliferative disorders: an analysis of V kappa gene usage, VJ joining and somatic mutation.
    Cannell PK; Amlot P; Attard M; Hoffbrand AV; Foroni L
    Leukemia; 1994 Jul; 8(7):1139-45. PubMed ID: 8035605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V gene rearrangement is required to fully activate the hypermutation mechanism in B cells.
    Roes J; Hüppi K; Rajewsky K; Sablitzky F
    J Immunol; 1989 Feb; 142(3):1022-6. PubMed ID: 2492327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal expansion of germline B-lineage acute lymphoblastic leukemia in severe combined immunodeficient mice.
    Felix CA; Wasserman R; Cesano A; Nowell PC; Hosler MR; Masterson M; Poplack DG; Santoli D
    Oncogene; 1995 Nov; 11(9):1753-9. PubMed ID: 7478603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.
    Umiel T; Pattengale P; Weinberg K
    Leukemia; 1993 Mar; 7(3):435-40. PubMed ID: 8445948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligoclonal immunoglobulin heavy-chain and T-cell receptor delta rearrangements persist in a recurrent acute lymphoblastic leukemia with one immunoglobulin kappa rearrangement as a clonal marker.
    Stolz F; Panzer S; Fischer S; Panzer-Grümayer ER
    Mod Pathol; 1999 Aug; 12(8):819-26. PubMed ID: 10463485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of malignant clone from acute lymphocytic leukemia].
    Zhu P; Liu J
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1057-61. PubMed ID: 11758256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgM heavy chain complementarity-determining region 3 diversity is constrained by genetic and somatic mechanisms until two months after birth.
    Shiokawa S; Mortari F; Lima JO; Nuñez C; Bertrand FE; Kirkham PM; Zhu S; Dasanayake AP; Schroeder HW
    J Immunol; 1999 May; 162(10):6060-70. PubMed ID: 10229847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.